Vice President Resume Template

thumbnail

About this resume

Industry
Carrer Level Executive
Written by Dua Khan
Order Similar Download Sample

Vice President Resume Sample

DR. ANITA R. SHARMA, PhD.

VICE PRESIDENT | HEAD OF REGULATORY AFFAIRS | PHARMACEUTICAL SECTOR

Bridgemont, UK • [email protected] • +44 203 993 4860

Results-oriented VP of Regulatory Affairs with a 15+ year track record of enabling clinical, CMC, and non-clinical development, with experience in both early- and late-stage product development. Dedicated to building high-performing teams, driving continuous improvement, and ensuring strict compliance with regulatory requirements.

  • Regulatory Strategy: Talented strategist with a history of creating effective regulatory plans, using a blend of technical and scientific knowledge, business acumen, and insight into the ever-changing regulatory landscape.
  • Liaison: Exceptional communicator and relationship builder with the capacity to act as a trusted liaison when dealing with regulatory agencies such as the FDA and EMA.
  • Technical Guidance: Influential subject matter expert and invaluable resource to internal teams and the senior executive committee with a history of guiding products from ideation to Proof of Concept.
  • Due Diligence: Able to conduct intensive due diligence on range of potential development opportunities.
  • Project Leadership: Skilled project leader with an aptitude for optimizing team performance during all phases of the project lifecycle from scoping and strategic analysis to execution, testing, and stakeholder engagement.
  • Problem Solving: Natural problem solver with history of overcoming obstacles by designing innovative solutions.

Areas of Expertise

  • US & Global Regulatory Strategies
  • NDA/BLA/IND/CTA Submissions
  • CMC, Clinical, Non-Clinical Planning
  • Project Management
  • Leadership & Mentoring
  • Process Improvement
  • Quality Assurance
  • Collaboration
  • Critical Thinking

Professional Experience

Biogalenica Therapeutics Ltd. | Bridgemont, UK                                                       12/2020 – Present
VP Head of Regulatory Affairs & Medical Writing

Currently orchestrating all aspects of the Regulatory Affairs function to facilitate nonclinical, clinical, and CMC development of novel antibody-fusion and bispecific antibody products for treatment of ulcerative colitis and severe acute alcoholic hepatitis. Achievements to date include the following:

  • Maintain comprehensive knowledge of legal directives and compliance requirements to provide ongoing guidance for senior executive peers and divisional leaders in an evolving regulatory landscape.
  • Foster consultative relationships with colleagues and strategic partners to enable a variety of programs.
  • Project-manage the development of ophthalmology products in collaboration with Boehringer Ingelheim.

Genora BioSolutions Ltd. | Remote, UK/Europe                                                        02/2020 – 10/2020
Head of Regulatory Strategy & Science

Provided regulatory leadership for complex clinical and CMC development operations focusing on autologous gene-edited hematopoietic stem cell therapeutics for sickle cell and other diseases. Highlights included the following:

  • Negotiated a decentralized late-stage manufacturing process for sickle cell gene edited product with FDA.
  • Leveraged technical awareness, regulatory knowledge, and business considerations to provide strategic insights and optimize development activities in collaboration with multi-disciplinary teams and external stakeholders.
  • Designed a robust regulatory strategy for gene-edited cellular therapies to align with global requirements.
  • Utilized outstanding interpersonal communication skills to act as a focal point for FDA interaction and led key submissions that enabled a decentralized late-stage manufacturing process.
  • Conducted regulatory assessment and due diligence for various business development opportunities.
  • Formed mutually beneficial strategic partnerships to drive programs forward and achieve ambitious objectives.
  • Worked in tandem with the Quality team to introduce GxP compliance to ensure that products are produced in line with best practice manufacturing, control, storage, and distribution processes.

VisceraBio International | London, UK                                                                          03/2019 – 01/2020
Executive Director – Regulatory Affairs – Ophthalmology

Managed the Regulatory Affairs function for this global Biosciences organization including in-depth strategic planning, analysis, and interaction with regulatory agencies (FDA). Achievements included:

  • Oversaw filing of BLA and chaired the BPD Type 2 meeting with the FDA to provide a detailed analysis of the development plan for the proposed Eylea® biosimilar.
  • Acted as regulatory lead to manage operational planning and filing of BLA for a proposed biosimilar to Lucentis® in collaboration with a strategic partner (bioeq).
  • Carried out due diligence activities for external assets and defined regulatory strategy for development of immune oncology therapeutic products.

Nexira Pharma Ltd. | Cambridge & Geneva                                                                 05/2014 – 03/2019
Senior Director – Regulatory Affairs, 01/2020 – 03/2020
Director – Regulatory Affairs, 06/2018 – 12/2019
Associate Director – Regulatory Affairs, 07/2015 – 05/2018
Senior Manager – Regulatory Affairs, 05/2014 – 06/2015

Spearheaded the Regulatory Affairs department with accountability for designing and implementing infrastructure and processes to maximize the likelihood of CMC, clinical and nonclinical development regulatory success of different development programs. Hired, trained, and mentored the regulatory and medical writing functional team. Provided expert guidance for senior executives and acted as a critical resource for colleagues on all matters involving regulatory affairs. Progressed to roles of increasing managerial responsibility due to outstanding contributions. Highlights:

  • Used strong interpersonal communication skills to liaise directly with review divisions at the FDA including Pre-IND, Type C, and Scientific Advice Meetings across four programs.
  • Optimized team performance and capability in supporting the clinical and CMC strategic development of new investigational biologics in the ophthalmology, liver disease (nonalcoholic steatohepatitis, primary biliary cholangitis, primary sclerosing cholangitis), diabetes, and immune oncology therapeutic space.
  • Created a range of procedures to facilitate document preparation and submission activities and developed processes for the medical writing group to improve report writing, protocol writing, and CSRs.
  • Played a leading role in the strategic planning cycle as a member of the Development Review Committee.
  • Provided leadership for a cross-functional team that achieved the approval of five initial regulatory applications in US and Australia and several clinical trial applications with limited resources in different therapeutic areas.
  • Successfully filed orphan applications (2 in EU, 1 in US) and a breakthrough designation request application.
  • Advised technical and non-technical colleagues on the content of documents, including drafting, review, and preparation of INDs, IMPDs, CTAs, briefing documents, and other regulatory filings for regulatory agencies.
  • Developed and introduced GxP processes in collaboration with Quality consultants.
  • Prepared the company for inspections/audit readiness by leading the completion of company SOPs.
  • Developed in vitro diagnostic strategy for a selection of patients in the oncology therapeutic space.
  • Devised a strategic plan to validate tools that support the use of patient reported outcomes as a co- primary endpoint for treatment of cachexia.

Oncorion Therapeutics | Surrey, UK                                                                              08/2012 – 05/2014
Manager – Regulatory Affairs, HIV

Delivered regulatory guidance for clinical operations teams during all phases of studies. Accomplishments included:

  • Acted as regulatory lead and FDA liaison supporting NDA first cycle review and resubmission for Vitekta®.
  • Filed an IND for novel HIV integrase inhibitor (small molecule).
  • Led a Recommendation for Temporary Use (RTU) submission to ANSM for Truvada for PrEP®.

Regulis Biopharma | Frankfurt, Germany                                                                    12/2008 – 07/2012
Senior Regulatory Associate

Enabled late state development activities as regulatory lead and FDA liaison for three investigational drug products (monoclonal antibodies). Highlights included the following:

  • Directed a portfolio of concurrent projects for candidates at various stages of development from pre- IND to Phase 3 in the metabolic, endocrine, cancer, and ophthalmic therapeutic space.
  • Obtained approval of three INDs submitted to the FDA (Division of Metabolism and Endocrinology Products) and several CTAs to Regulatory Agencies.
  • Managed the Module 1 and Module 2 clinical sections of Biologic License Application for Eylea®.
  • Attended and presented at FDA meetings (Type C and End of Phase 2) and other Agency Meetings (CHMP, PMDA and Health Canada).
  • Worked in conjunction with SMEs and Sanofi team members to remove partial and complete holds on INDs.
  • Owned all documentation including annual reports, periodic safety reports, development safety update reports, and investigator brochures.

Early Career Roles

Scientist, Regulis Biopharma
Postdoctoral Fellow, European Biomedical Research Institute
Postdoctoral Research Associate, University of Lausanne / University of Bergen

Education

PhD in Medicinal Chemistry and Pharmaceutics
University of Edinburgh, College of Pharmacy
Awarded John Bruce Scholarship for Outstanding Graduate Student in Pharmaceutical Sciences

Bachelor of Pharmaceutical Sciences
Mumbai Institute of Chemical Technology (Formerly called University Department of Chemical Technology)

Publications

  • Menon, P. 11 October 2016. Global Regulatory Strategy. Regulatory Focus Magazine (online).
  • Lu, Y, Lian, H, Sharma, P. Schrieber-Agus, N, Russell, RG, Chin, L., Van der Horst, GT, Bregman, DB. 2001. Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer- predisposed Ink4a/ARF knockout mice. Mol Cell Biol. 21(5):1810-1818.
  • Sharma, P. and Schriber-Agus, N. 1999. Mouse models of prostate cancer. Oncogene 19, 5349-5355.
  • Duan, D., Sharma P., Dudus, L, Zhang, Y., Sanlioglu, S., Yan, Z., Yue, Y., Lester, R., Yang, J., Fisher, K.J. and Englehardt, J.F. 1999. Formation of adeno-associated virus circular genomes is differently regulated by adenovirus E4 ORF6 and E2a gene. J. Virology. 73(1) 161-169.
  • Sharma, P., Dudus, L., Nielsen, P.A., Clausen, H., Yankaskas JR, Hollingsworth MA and Engelhardt, J.F., 1998. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am. J. Resp. Cell and Mol. Biol. 19(1) 8568- 8577 (journal cover article).
  • Duan, D., Sharma, P., Yang J, Yue Y., Dudus L., Zhang, Y., Fisher, K.J. and Engelhardt, J.F. 1998. Circular Intermediates of Recombinant Adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virology. 72 (11) 8568-8577.
  • Sharma, P M., Sarkar, M.G., Virmani, A.K., Gazdar, A.F. and Sachdev, G.P. 1999. Evidence of Mucin Secretion in Human Lung Adenocarcinoma Cell Lines NCIH650 and NCIH2077 and Effect of Select Secretagogues on Mucin Secretion. Bioscience Reports, 19(5):473-48.

Patents

  • US 7,666,622 (issued February 23, 2010) entitled “Monomeric Self-associating Fusion Polypeptides and Therapeutics Uses Therof”
  • US 7,608,430 (issued October 27, 2009) entitled “Interferon-gamma Antagonists and Therapeutic Uses Thereof”
  • US 7,557,084 (issued July 7, 2009) entitled “IL-18 Specific Polypeptides and Therapeutic Uses Thereof”

How to Write an Impactful Vice President Executive Resume: The Complete Guide for Pharmaceutical and Biotech Leaders

Having a career in pharmaceutical regulatory affairs means balancing science, strategy, and cross-border compliance. Whether you’re eyeing the next VP seat or want to showcase your expertise in clinical, CMC, and global submissions, your resume must be written by professional certified resume writers online and tell a story of both biotechnical mastery and strategic leadership.

Let’s break down the essential steps to building a compelling Regulatory Affairs resume, using insights from the career trajectory of Dr. Anita R. Sharma, PhD, one of the sector’s standout leaders.

1. Start with a Commanding Profile Statement

Open with your unique value:
Immediately set the tone by summarizing your years of experience, the depth of your regulatory knowledge (clinical, CMC, non-clinical), and your talent for building teams and ensuring compliance in complex, ever-evolving landscapes.

Example: Results-driven VP of Regulatory Affairs with 15+ years enabling product development, compliance, and cross-functional leadership across early- and late-stage programs. Expert at translating scientific discovery into actionable regulatory strategy for successful global submissions and approvals.

2. Spotlight Strategic and Technical Expertise

Section off core skills in a visually distinct list. Think:

Free resume critique
from certified writers!
  • US & Global Regulatory Strategy
  • NDA/BLA/IND/CTA Submissions
  • CMC/Clinical/Non-Clinical Development
  • Team Leadership & Talent Development
  • FDA/EMA Liaison & Relationship Management
  • Due Diligence & M&A Assessment
  • Project & Lifecycle Management
  • GxP/Quality Compliance
  • Medical & Regulatory Writing
  • Audit & Inspection Preparedness

Tip from biotech resume writers: Don’t shy from including major scientific or biotechnical skills unique to your portfolio (e.g., biosimilars, gene-editing, orphan drugs).

3. Lead with Achievements and Results, Not Just Responsibilities

Quantify and contextualize your impact:
For each role, highlight tangible outcomes:

  • “Negotiated decentralized late-stage manufacturing process with FDA for gene-edited product, enabling accelerated approval pathway.”
  • “Guided five successful regulatory applications across US and Australia, delivering results despite resource constraints.”
  • “Secured orphan and breakthrough designations in EU and US for novel biologics, driving pipeline value and recognition.”

Tip: Focus on the business and scientific value you delivered, not just the tasks you performed.

4. Emphasize Agency and Cross-Functional Leadership

Show how you’ve been the linchpin:

  • “Chaired BPD Type 2 meeting with FDA for biosimilar product; provided strategic input that shaped clinical development plan.”
  • “Formed strategic partnerships, acting as primary regulatory liaison between cross-functional teams, external collaborators, and executive committees.”
  • “Led multi-disciplinary teams through GxP compliance and inspection readiness, ensuring audit success.”

5. Demonstrate Advanced Project Management

Highlight your leadership from inception through execution:

  • “Project-managed development of antibody-fusion therapeutics, orchestrating teams across clinical, nonclinical, and CMC functions to meet regulatory milestones.”
  • “Implemented SOPs and infrastructure for regulatory and medical writing teams, driving continuous process improvement.”

6. Integrate Technical Publications, Patents, and Credentials

For senior candidates, a dedicated section for publications, patents, or speaking engagements can elevate your authority:

  • List peer-reviewed articles, especially in regulatory or scientific journals.
  • Highlight issued patents relevant to your field.
  • If you’ve authored major industry reports or presented at international conferences, mention these as career differentiators.

7. Outline a Global Mindset and Multi-Agency Experience

Show your ability to navigate international regulations and collaborate with multiple health authorities:

Need a career boost? get LinkedIn profile makeover
Hire Experts
image
  • “Led regulatory strategy for global biosciences organization, including interaction with FDA, EMA, ANSM, CHMP, PMDA, and Health Canada.”
  • “Defined regulatory approaches to meet both US and global requirements for gene-edited and biosimilar products.”

8. Build a Progressive Narrative

Show career growth through roles of increasing scope, complexity, and authority:

  • Move from scientist or associate to manager, director, and VP roles.
  • Note promotions or expansions of responsibility.
  • If you have early career experience in academia or R&D, link this to your later regulatory expertise.

9. List Education and Continuous Professional Development

A PhD (or advanced degree) is often a baseline in this field. List:

  • Doctoral and undergraduate degrees (with specialties and awards)
  • Relevant certifications (e.g., RAC, PMP)
  • Notable scholarships or recognition

10. Bonus: Leadership Qualities and Soft Skills

Modern regulatory leaders are change agents. Include:

  • “Natural problem-solver with a record of designing innovative regulatory solutions for complex challenges.”
  • “Celebrated mentor and team builder; developed robust training and onboarding programs for new regulatory staff.”
  • “Known for influencing policy and shaping regulatory pathways at both regional and global levels.”

Sample Section Outline for a Regulatory Affairs Executive Resume

  1. Contact Details
  2. Executive Summary/Profile
  3. Key Skills & Areas of Expertise
  4. Professional Experience & Impact (with bullet-pointed achievements)
  5. Publications, Patents, and Thought Leadership
  6. Education & Credentials
  7. Professional Development & Memberships

Final Checklist for Regulatory Affairs Leaders

  • Make every bullet quantifiable or outcome-based.
  • Highlight multi-agency, global, or cross-functional work.
  • Keep the tone professional, factual, and action-oriented.
  • Be concise, two to three pages is ideal for this level.
  • Back up big claims with specific projects, approvals, or metrics.

By following these steps from Resume Writing Lab’s healthcare executive resume writing service, your CV will reflect the technical depth, regulatory sophistication, and executive leadership needed to lead teams and shape the future of compliance and development in the pharmaceutical industry.

Ready to write your resume? Get started
Want a free resume analysis? Review my resume